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INTRODUCTION:  Malignant  peripheral  nerve  sheath  tumors  (MPNSTs)  are  rare,  up  to one half  of the  MPN-
STs  occur  in  patients  with  neuroﬁbromatosis  type-1  (NF-1),  while  the  rest  are sporadic.  Here, we  present
a 52-year-old  woman  with  MPNST  of the  vulva  without  NF-1.  We  will discuss  basics  of  the disease,
treatment  options  and follow-up  strategies.
PRESENTATION  OF CASE:  52-year-old  female  admitted  to our  hospital  with  complaint  of abnormal  uterine
bleeding  and  rapidly  growing  vulvar  mass.  Excisional  biopsy  of the  mass  showed  MPNST  of the  vulva.
Afterwards,  the  patient  underwent  radical  vulvectomy  with  inguinofemoral  lymph  node  dissection.  Short
after the  surgery,  multiple  lung  metastasis  were  shown  and  responded  to  chemotherapy,  but  rapid  local
recurrence  occurred  short  after  the  completion  of  the  chemotherapy.
DISCUSSION:  The  primary  treatment  option  in  MPNSTs  is  surgical  excision  with  or  without  adjuvant
therapy.  There  is not  enough  data  about  the  role  of systemic  chemotherapy  in  the  management  of  MPNSTs
and it still  remains  controversial.
CONCLUSION:  In general,  radiation  therapy  has  not  been  demonstrated  to  improve  overall  survival.  Com-
plete surgical  resection  of the  primary  tumor  is  the mainstay  of  the  treatment.
©  2014  The  Authors.  Published  by Elsevier  Ltd.  on behalf  of  Surgical  Associates  Ltd.  This  is  an  open
 the Caccess  article  under
. Introduction
Malignant peripheral nerve sheath tumors (MPNSTs) are rare;
PNST of the vulva is extremely rare and devastating tumor. Up to
ne half of the MPNSTs occur in patients with neuroﬁbromatosis
ype-1 (NF-1), while the rest are sporadic.1
Optimal treatment of MPNST is surgical resection of the tumor
ith adequate clear margins, if it is not possible adjuvant radiation
herapy with or without chemotherapy may  be necessary. Manage-
ent of locally advanced tumors is challenging and the prognosis is
oor. Poor prognostic factors are: tumor size larger than 5 cm,  high
umor grade, coexistence with NF-1, advanced patient age, distant
etastasis and inability to achieve tumor free margins at the initial
urgery.2
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Here, we  present a 52-year-old woman with MPNST of the vulva
without NF-1. We  will discuss basics of the disease, treatment
options and follow-up strategies.
2. Case report
A 52-year-old woman admitted to our hospital’s gynecology
department with abnormal uterine bleeding and rapidly growing
vulvar mass in the left labium majus. The physical examination of
the patient was completely normal without any stigmata of NF-1.
Hemoglobin levels and serum biochemical parameters were in nor-
mal  range. Trans-vaginal ultrasound revealed multiple intramural
and submucous leiomyomas with normal adnexa. The mass in the
left labium majus was semi-mobile and 5 cm in diameter.
A total abdominal hysterectomy and bilateral salpingo-
oophorectomy was  performed for uterine leiomyomas and
abnormal vaginal bleeding. Afterwards, the vulvar mass was
excised and sent for frozen section pathology. Frozen section result
was not precise for diagnosis and it is indicated that ﬁnal diagnosis
could be made with parafﬁn sections.Parafﬁn section result for the tumor was high-grade sarcoma
with myxoid areas and epithelial component and spindle cells with
tumor positive surgical margins. The tumor had high mitotic activ-
ity, that, 10 to 15 mitotic ﬁgures were seen per 10 high-power ﬁeld.
ssociates Ltd. This is an open access article under the CC BY-NC-SA license
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Fig. 1. Epithelioid cells and mitotic ﬁgures. H&E staining, 200× actual magniﬁcation.
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were no nodal involvement in our case and there is not enoughig. 2. Wavy clusters of spindle cells. H&E staining, 200× actual magniﬁcation.
arge areas of epithelioid cells (Fig. 1) and clusters of wavy spindle
ells (Fig. 2) were present. Tumor cells were positive for S-100 and
egative for cytokeratin, CEA and EMA  (Fig. 3). Uterus and adnexa
ere normal except large and multiple myomas. The patient was
eferred to our gynecologic oncology department two weeks after
he initial surgery. Vulvar mass had grown to 6 × 3 cm in the two
eeks. No distant metastases were noted in thoraco-abdomino-
elvic computerized tomography scans. Radical vulvectomy with
ilateral inguino-femoral lymph node dissection was performed.
inal pathology was consistent with MPNST of the vulva. All
issected lymph nodes, total of 17, were negative for tumoral
nvolvement. 6 cycles of adjuvant Ifosfamide, Mesna and Adri-
mycin (IMA) combination chemotherapy was planned. The patient
as discharged from the hospital after 5 days of uneventful post-
perative course.
Three weeks after the radical vulvectomy, just before the ﬁrst
ycle of chemotherapy, thorax CT revealed multiple metastatic
odules in the lungs. After the third chemotherapy cycle, thorax CT
howed rapid response to the therapy, all metastatic nodules were
isappeared. After the completion of the sixth cycle, the patient
omplained about pelvic pain. Pelvic CT showed tumoral invasion of
he iliac bones. Palliative radiation therapy was planned for severe
ain.Fig. 3. Diffuse positive immunostaining for S-100 protein, 100× actual magniﬁca-
tion.
Written informed consent was  obtained from the patient for
publication of this case report and accompanying images. A copy
of the written consent is available for review by the Editor-in-Chief
of this journal on request.
3. Discussion
The incidence of MPNST in the general population is 1 per 1
million people per year; the most common localizations for MPNSTs
are extremities, trunk, head and neck. Less than 1% of all MPNSTs are
located in the vulva. MPNSTs are locally aggressive and tend to recur
or metastasize after surgical excision1 and even with aggressive
surgical and radiation treatment, the prognosis is not good.3 In the
literature, ﬁve-year survival is between 34 and 64 percent.2,4
Microscopic features of MPNSTs are varied as they originate
from schwann cells, the pluripotential cells of neural crest.5 The
tumor cells show positive staining for S-100, negative staining
for cytokeratin, actin smooth muscle, HMB45 and alpha-1 anti-
trypsin.6 Microscopic ﬁndings of our case were clusters of wavy
spindle cells, epithelioid cells on the background, that showing
myxoid changes. Tumor cells showed neural and vascular invasion.
Microscopic ﬁndings of vulvar MPNSTs in the literature are quite
similar with our case. The most common ﬁndings are wavy spin-
dle cells and epithelioid cells. High mitotic activity and coagulative
necrosis are typically present in high-grade tumors.
The most presenting symptom of the disease is rapid growing
mass and often accompanied by pain.7 MPNST rising from female
external genitalia is extremely rare. The median age of patients with
MPNST of the vulva is 40 years in the literature.8
The primary treatment option is surgical excision with or with-
out adjuvant therapy. If complete surgical excision is difﬁcult to
achieve, then neo-adjuvant radiotherapy or chemotherapy may be
an appropriate option. The most predictive factor for survival seems
to be complete resection of the tumor with clear surgical mar-
gins. There are only 12 reported cases on MPNST of the vulva in
the literature. Due to rarity of the condition, there is no consensus
about optimal treatment or adjuvant therapy strategies. Most of the
cases had undergone wide local excision without further adjuvant
therapy. Only three patients of vulvar MPNST had undergone rad-
ical vulvectomy with lymph node dissection9,10 as our case. Theredata in the literature about necessity of lymph node dissection in
MPNST because disease spread seems to be hematogenous rather
than lymphatic way.
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There is not enough data about the role of systemic
hemotherapy in the management of MPNSTs and it still remains
ontroversial.11 Adjuvant therapy after initial surgery in high-risk
atients and neo-adjuvant therapy in patients who have large,
nresectable or metastatic disease may  be useful for systemic and
ocal control of the disease. The most studied regimen for MPNST
s Ifosfamide and Adriamycin (Doxorubicin) based regimens. Based
n these information we planned 6 cycles of adjuvant IMA  combi-
ation chemotherapy.
MPNSTs have been demonstrated to have high local recurrence
ates. Terada et al.10 advocated that radiotherapy is ineffective
s primary therapy, but Lambrou et al.7 showed utility of neo-
djuvant radiation therapy in a recurrent large MPNST of the vulva.
n general, radiation therapy has not been demonstrated to improve
verall survival in patients with MPNST, but it is shown that adju-
ant radiation therapy improves local control of the disease.12
Local recurrence rate of MPNSTs following surgical resection
anges 20–40% and local recurrences tend to occur short after initial
esection. The most important risk factor for recurrence is incom-
lete resection and positive surgical margins. Signiﬁcant number of
atients with MPNST tend to have metastatic disease at the time of
iagnosis. Lungs are the most common site for distant metastasis.
he natural prognosis of MS  is poor, in addition to this; recurrent
nd metastatic disease, large tumor size and incomplete resection
re related with poorer prognosis.
MPNSTs remain a diagnostic and therapeutic challenge. Com-
lete surgical resection of the primary tumor is the mainstay of the
treatment and additional treatment options such as chemother-
apy and radiation therapy warrants local and distant control of the
disease.
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Key learning points
• Clinical diagnosis, surgical management and adjuvant therapy options for malignant peripheral nerve sheath tumor
(MPNST) of the vulva.
• MPNSTs are extremely malignant and have high potential for local recurrence.
• The prognosis depends on complete resection of the tumor with clear surgical margins.
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